Adherence

Biogen and Happify partner on digital support for MS patients

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. The digital toolkit is designed to keep patients informed of new treatments, help them adhere to their prescribed therapies, encourage behaviours aimed at improving their wellbeing and …

Biogen and Happify partner on digital support for MS patients Read More »

Apple adds medication tracking to iPhone and Apple Watch

Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will help them manage and track their use of medicines. The new tool works as a component of Apple’s Health app and will let users add drugs or other health products like vitamins and supplements to a personal …

Apple adds medication tracking to iPhone and Apple Watch Read More »

Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at the pharmacy counter can help lower costs, improve adherence and reduce health disparities. This common-sense solution can help us build a more affordable and equitable health care system and help …

Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans Read More »

Ashfield turns to Popit for digital patient support tool

Ashfield Engage has agreed a deal to incorporate Popit’s digital tools in its patient support programmes, with the aim of improving adherence to treatments.  Finnish startup Popit has developed a device called Popit Sense that clips to a blister pill sheet and uses technology to monitor whether a dose has been taken, sending reminders to …

Ashfield turns to Popit for digital patient support tool Read More »

Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds

A new analysis by IQVIA looked at three cost-sharing assistance programs and found that from 2018 to 2020, 25% to 36% of patients discontinued treatment when they faced an unexpectedly high out-of-pocket cost of $1,500 or more in the middle of the plan year. These unexpected costs were caused by accumulator adjustment programs operated by …

Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds Read More »

Sharing rebates can improve access to medicines and increase health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Dr. Leah …

Sharing rebates can improve access to medicines and increase health equity Read More »

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of the seven therapeutic areas that IQVIA analyzed, including anticoagulants, asthma/COPD, depression, diabetes, HIV, multiple sclerosis and oncology treatments, average patient cost exposure between 2015 and 2019 …

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas Read More »